Procyon Corporation Announces the Results of the Special Meeting of Shareholders
Common and Preferred shareholders are to receive net asset-sale proceeds after dissolution.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Shareholders were presented with two substantive proposals for vote, both of which passed:
Proposal No. 1: “To approve the sale of the Purchased Assets of the Company (the “Asset Sale”) pursuant to the Asset Purchase Agreement dated August 31, 2026 (the “Asset Purchase Agreement”), by and between AMERX Health Care Corporation, a wholly owned subsidiary of Procyon Corporation (“AMERX” or the “Seller”) and Frontrunner Investments LLC, a
Proposal No. 2: “To approve the liquidation and dissolution of the Company (the “Dissolution”), which, if approved, will authorize the Company to dissolve and liquidate and to distribute the net proceeds to Shareholders (the “Distribution”) (the “Dissolution and Distribution Proposal”).”
The votes for these two proposals were as follows:
Proposal 1:
Votes for: 6,085,553
Votes against: 226,328
Abstentions: 36,100
Proposal 2:
Votes for: 6,084,552
Votes against: 226,329
Abstentions: 37,100
With respect to the Asset Sale, the Company expects to conduct a Closing of the Asset Purchase Agreement as soon as certain arrangements are in place, in approximately late November or early December, 2026.
After the Asset Sale closes, the Company will thereafter file Articles of Dissolution with the
After the Dissolution and wind up is concluded and the Distribution to shareholders made, the Company will cease its operations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261026442883/en/
James B. Anderson
Chief Financial Officer
(727) 443-0350
Source: Procyon Corporation